Thomas J. Kipps
Thomas J. Kipps
Professor of Medicine, UC San Diego
Verified email at ucsd.edu
Title
Cited by
Cited by
Year
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin, CD Dumitru, M Shimizu, R Bichi, S Zupo, E Noch, H Aldler, ...
Proceedings of the national academy of sciences 99 (24), 15524-15529, 2002
60952002
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino, GA Calin, M Fabbri, MV Iorio, M Ferracin, M Shimizu, ...
Proceedings of the National Academy of Sciences 102 (39), 13944-13949, 2005
42432005
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National …
M Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...
Blood 111 (12), 5446-5456, 2008
33982008
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin, M Ferracin, A Cimmino, G Di Leva, M Shimizu, SE Wojcik, ...
New England Journal of Medicine 353 (17), 1793-1801, 2005
28492005
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia
RR Furman, JP Sharman, SE Coutre, BD Cheson, JM Pagel, P Hillmen, ...
New England Journal of Medicine 370 (11), 997-1007, 2014
17062014
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
GA Calin, CG Liu, C Sevignani, M Ferracin, N Felli, CD Dumitru, ...
Proceedings of the National Academy of Sciences 101 (32), 11755-11760, 2004
16722004
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
JC Byrd, JR Brown, S O'Brien, JC Barrientos, NE Kay, NM Reddy, ...
New England Journal of Medicine 371 (3), 213-223, 2014
14432014
Williams hematology
JT Prchal, MM Levi
New York: The McGraw-Hill Companies, 2010
1402*2010
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald, AA Alizadeh, G Widhopf, R Simon, RE Davis, X Yu, L Yang, ...
Journal of Experimental Medicine 194 (11), 1639-1648, 2001
13212001
Targeting BCL2 with venetoclax in relapsed chronic lymphocytic leukemia
AW Roberts, MS Davids, JM Pagel, BS Kahl, SD Puvvada, JF Gerecitano, ...
New England Journal of Medicine 374 (4), 311-322, 2016
13162016
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger, TJ Kipps
Blood 107 (5), 1761-1767, 2006
13022006
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ...
New England Journal of Medicine 351 (9), 893-901, 2004
11082004
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
JA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, ...
New England Journal of Medicine 373 (25), 2425-2437, 2015
10762015
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.
F Fais, F Ghiotto, S Hashimoto, B Sellars, A Valetto, SL Allen, P Schulman, ...
The Journal of clinical investigation 102 (8), 1515-1525, 1998
9961998
Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell–derived factor-1
JA Burger, N Tsukada, M Burger, NJ Zvaifler, M Dell'Aquila, TJ Kipps
Blood, The Journal of the American Society of Hematology 96 (8), 2655-2663, 2000
8532000
MiR-15a and miR-16-1 cluster functions in human leukemia
GA Calin, A Cimmino, M Fabbri, M Ferracin, SE Wojcik, M Shimizu, ...
Proceedings of the National Academy of Sciences 105 (13), 5166-5171, 2008
8422008
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas
GA Calin, C Liu, M Ferracin, T Hyslop, R Spizzo, C Sevignani, M Fabbri, ...
Cancer cell 12 (3), 215-229, 2007
7942007
Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181
Y Pekarsky, U Santanam, A Cimmino, A Palamarchuk, A Efanov, ...
Cancer research 66 (24), 11590-11593, 2006
7772006
Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease
AW Roberts, JF Seymour, JR Brown, WG Wierda, TJ Kipps, SL Khaw, ...
Journal of Clinical Oncology 30 (5), 488, 2012
7372012
Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.
EA Ranheim, TJ Kipps
The Journal of experimental medicine 177 (4), 925-935, 1993
7081993
The system can't perform the operation now. Try again later.
Articles 1–20